Yunnan Dongjun Pharmaceutical Co., Ltd. Sustainability Profile
Yunnan Dongjun Pharmaceutical Co., Ltd., commonly referred to as Dongjun Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in China. Established in 2001, the company has made significant strides in the development and production of traditional Chinese medicine and modern pharmaceuticals, primarily serving the Yunnan province and expanding its reach across various regions in China. Dongjun Pharmaceutical is renowned for its unique formulations that blend ancient herbal practices with contemporary scientific methods. The company’s core product offerings include a range of herbal extracts and health supplements, which are distinguished by their high quality and efficacy. With a commitment to innovation and quality, Dongjun has positioned itself as a trusted name in the market, achieving notable recognition for its contributions to health and wellness.
DitchCarbon Score
How does Yunnan Dongjun Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Yunnan Dongjun Pharmaceutical Co., Ltd.'s score of 20 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Yunnan Dongjun Pharmaceutical Co., Ltd.'s reported carbon emissions
Yunnan Dongjun Pharmaceutical Co., Ltd., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and climate commitments. However, without specific emissions data or targets, it is challenging to assess Yunnan Dongjun Pharmaceutical's environmental impact or commitment to reducing carbon emissions. As the industry evolves, it is anticipated that Yunnan Dongjun Pharmaceutical will align with broader climate initiatives and set measurable targets to contribute to global sustainability efforts.
How Carbon Intensive is Yunnan Dongjun Pharmaceutical Co., Ltd.'s Industry?
How Carbon Intensive is Yunnan Dongjun Pharmaceutical Co., Ltd.'s Location?
Yunnan Dongjun Pharmaceutical Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Yunnan Dongjun Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
